Sonoma Pharmaceuticals Inc (SNOA)
0.1505
-0.01
(-4.08%)
USD |
NASDAQ |
Apr 19, 16:00
0.1505
0.00 (0.00%)
After-Hours: 19:44
Sonoma Pharmaceuticals Gross Profit Margin (Quarterly): 46.53% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.53% |
| September 30, 2023 | 36.25% |
| June 30, 2023 | 35.13% |
| March 31, 2023 | 28.67% |
| December 31, 2022 | 28.23% |
| September 30, 2022 | 46.11% |
| June 30, 2022 | 41.33% |
| March 31, 2022 | 4.18% |
| December 31, 2021 | 41.45% |
| September 30, 2021 | 33.15% |
| June 30, 2021 | 39.44% |
| March 31, 2021 | -8.99% |
| December 31, 2020 | 40.42% |
| September 30, 2020 | 43.37% |
| June 30, 2020 | 39.10% |
| March 31, 2020 | 38.33% |
| December 31, 2019 | 45.53% |
| September 30, 2019 | 46.01% |
| June 30, 2019 | 51.01% |
| March 31, 2019 | 42.79% |
| December 31, 2018 | 53.92% |
| September 30, 2018 | 49.14% |
| June 30, 2018 | 39.62% |
| March 31, 2018 | 36.44% |
| December 31, 2017 | 48.90% |
| Date | Value |
|---|---|
| September 30, 2017 | 42.73% |
| June 30, 2017 | 45.95% |
| March 31, 2017 | 48.32% |
| December 31, 2016 | 50.76% |
| September 30, 2016 | 37.03% |
| June 30, 2016 | 37.19% |
| March 31, 2016 | 37.71% |
| December 31, 2015 | 18.32% |
| September 30, 2015 | 51.55% |
| June 30, 2015 | 50.90% |
| March 31, 2015 | 50.10% |
| December 31, 2014 | 51.46% |
| September 30, 2014 | 53.06% |
| June 30, 2014 | 56.19% |
| March 31, 2014 | 47.46% |
| December 31, 2013 | 64.04% |
| September 30, 2013 | 66.15% |
| June 30, 2013 | 65.24% |
| March 31, 2013 | 65.61% |
| December 31, 2012 | 69.80% |
| September 30, 2012 | 70.70% |
| June 30, 2012 | 71.19% |
| March 31, 2012 | 63.71% |
| December 31, 2011 | 66.38% |
| September 30, 2011 | 75.84% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-8.99%
Minimum
Mar 2021
51.01%
Maximum
Jun 2019
35.54%
Average
39.44%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -76.57% |
| Return on Assets | -34.16% |
| Return on Invested Capital | -74.41% |
| Profit Margin (Quarterly) | -27.60% |
| Operating Margin (Quarterly) | -26.90% |
| Return on Net Operating Assets | -64.76% |